Literature DB >> 10921959

Identification of members of the Burkholderia cepacia complex by species-specific PCR.

P W Whitby1, K B Carter, K L Hatter, J J LiPuma, T L Stull.   

Abstract

Definitive identification of the species in the Burkholderia cepacia complex by routine clinical microbiology methods is difficult. Phenotypic tests to identify B. multivorans and B. vietnamiensis have been established; more recent work indicates B. stabilis may also be identified by growth characteristics and biochemical tests. However, attempts to identify genomovars I and III have, thus far, proved unsuccessful. Previously, we demonstrated the utility of two primer pairs, directed to the rRNA operon, to specifically identify the B. cepacia complex in a PCR. One of these primer pairs, G1-G2, only amplified a DNA fragment from genomovars I and III and B. stabilis in a PCR with genomic DNA isolated from prototypical strains representing the five genomovars. Sequence analysis of the rRNA operon for all the genomovars indicated that this primer pair targeted a region shared by these isolates. Further analysis revealed a region of heterogeneity between genomovar III and B. stabilis internal to the amplified product of G1-G2. Primers designed to target this region were tested with prototypical strains following an initial amplification with the G1-G2 primer pair. New primers specific for the prototypical genomovar III and B. stabilis were designated SPR3 and SPR4, respectively. Analysis of 93 isolates representing 18 genomovar I, 13 B. multivorans, 36 genomovar III, 11 B. stabilis, and 15 B. vietnamiensis isolates was performed. DNA from all isolates of genomovars I and III and B. stabilis was amplified by G1-G2. Genomovar III isolates yielded a product with SPR3/G1 while B. stabilis amplified with SPR4-G1. Genomovar I isolates were amplified by either SPR3-G1 or SPR4-G1, but not both. B. multivorans yielded a product with SPR3-G1 but not G1-G2, and B. vietnamiensis isolates were negative in all PCRs. Thus using an algorithm with G1-G2, SPR3-G1, and SPR4-G1 primers in a PCR analysis, genomovar III isolates can be separated from B. stabilis and the identity of B. multivorans and B. vietnamiensis can be confirmed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921959      PMCID: PMC87159     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Species-specific PCR as a tool for the identification of Burkholderia gladioli.

Authors:  P W Whitby; L C Pope; K B Carter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

3.  Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.

Authors:  J J LiPuma; B J Dulaney; J D McMenamin; P W Whitby; T L Stull; T Coenye; P Vandamme
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

4.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

5.  Detection of Pseudomonas (Burkholderia) cepacia using PCR.

Authors:  P W Campbell; J A Phillips; G J Heidecker; M R Krishnamani; R Zahorchak; T L Stull
Journal:  Pediatr Pulmonol       Date:  1995-07

6.  Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis.

Authors:  R F Taylor; H Gaya; M E Hodson
Journal:  Respir Med       Date:  1993-04       Impact factor: 3.415

7.  Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia.

Authors:  D E Lacy; D A Spencer; A Goldstein; P H Weller; P Darbyshire
Journal:  J Infect       Date:  1993-11       Impact factor: 6.072

8.  Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia.

Authors:  E M O'Callaghan; M S Tanner; G J Boulnois
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

9.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

10.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more
  9 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.

Authors:  P W Whitby; K B Carter; J L Burns; J A Royall; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.

Authors:  A McDowell; E Mahenthiralingam; J E Moore; K E Dunbar; A K Webb; M E Dodd; S L Martin; B C Millar; C J Scott; M Crowe; J S Elborn
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays.

Authors:  T Coenye; L Liu; P Vandamme; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Burkholderia cenocepacia keratitis.

Authors:  Geeta Behera; Radha Sugumar; Sujata Sistla; Mary Stephen; Subashini Kaliaperumal; K Ramesh Babu
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

7.  Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Authors:  Christine Segonds; Patricia Clavel-Batut; Michelle Thouverez; Dominique Grenet; Alain Le Coustumier; Patrick Plésiat; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

8.  Recovery of Herbaspirillum species from persons with cystic fibrosis.

Authors:  Theodore Spilker; Ahmet Z Uluer; Francisco M Marty; Wendy W Yeh; Julie H Levison; Peter Vandamme; John J Lipuma
Journal:  J Clin Microbiol       Date:  2008-06-04       Impact factor: 5.948

9.  Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study.

Authors:  Mónica V Cunha; Jorge H Leitão; Eshwar Mahenthiralingam; Peter Vandamme; Luís Lito; Celeste Barreto; Maria José Salgado; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.